Business Description
OncoSil Medical Ltd
ISIN : AU000000OSL3
Description
OncoSil Medical Ltd is an Australian based medical device company focused on localized radiation treatments for patients with pancreatic and bile duct cancer. The product includes OncoSil, a silicon and phosphorus (p32) beta emitter radiation therapy for the treatment of pancreatic cancer.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 45.72 | |||||
| Equity-to-Asset | 0.63 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -6.91 | |||||
| Beneish M-Score | -2.92 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -21.6 | |||||
| 3-Year EPS without NRI Growth Rate | -21.6 | |||||
| 3-Year FCF Growth Rate | -26 | |||||
| 3-Year Book Growth Rate | -37 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.9 | |||||
| 9-Day RSI | 47.5 | |||||
| 14-Day RSI | 46.53 | |||||
| 6-1 Month Momentum % | -41.18 | |||||
| 12-1 Month Momentum % | -47.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.74 | |||||
| Quick Ratio | 2.74 | |||||
| Cash Ratio | 2.14 | |||||
| Days Sales Outstanding | 757.49 | |||||
| Days Payable | 299.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -24.2 | |||||
| Shareholder Yield % | -64.27 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -683.26 | |||||
| Operating Margin % | -5441 | |||||
| Net Margin % | -4898.75 | |||||
| FCF Margin % | -4297.91 | |||||
| ROE % | -178.08 | |||||
| ROA % | -137.57 | |||||
| ROIC % | -2648.47 | |||||
| ROC (Joel Greenblatt) % | -5607.69 | |||||
| ROCE % | -187.05 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.5 | |||||
| Price-to-Tangible-Book | 2.5 | |||||
| EV-to-EBIT | -0.81 | |||||
| EV-to-EBITDA | -0.83 | |||||
| EV-to-Revenue | 42.26 | |||||
| EV-to-Forward-Revenue | 6.23 | |||||
| EV-to-FCF | -0.98 | |||||
| Earnings Yield (Greenblatt) % | -123.46 | |||||
| FCF Yield % | -69.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
OncoSil Medical Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 0.239 | ||
| EPS (TTM) (A$) | -0.008 | ||
| Beta | 1.36 | ||
| Volatility % | 48.71 | ||
| 14-Day RSI | 46.53 | ||
| 14-Day ATR (A$) | 0.000838 | ||
| 20-Day SMA (A$) | 0.00555 | ||
| 12-1 Month Momentum % | -47.06 | ||
| 52-Week Range (A$) | 0.004 - 0.014166 | ||
| Shares Outstanding (Mil) | 2,976.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
OncoSil Medical Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
OncoSil Medical Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
OncoSil Medical Ltd Frequently Asked Questions
What is OncoSil Medical Ltd(ASX:OSL)'s stock price today?
The current price of ASX:OSL is A$0.01. The 52 week high of ASX:OSL is A$0.01 and 52 week low is A$0.00.
When is next earnings date of OncoSil Medical Ltd(ASX:OSL)?
The next earnings date of OncoSil Medical Ltd(ASX:OSL) is .
Does OncoSil Medical Ltd(ASX:OSL) pay dividends? If so, how much?
OncoSil Medical Ltd(ASX:OSL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers